Image

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

A Comparison of Two Brief Suicide Prevention Interventions Tailored for Youth on the Autism Spectrum

Recruiting
12-99 years
All
Phase N/A

Powered by AI

Overview

Rates of suicide have increased significantly over the past two decades, particularly among youth. Compared to the general population, autistic people are significantly more likely to think about suicide, attempt suicide, and die by suicide. Autistic individuals have identified suicide prevention as a top research priority; however, little is known about how to best help autistic youth at risk for suicide. The purpose of this study is to compare the effectiveness, feasibility, and acceptability of two suicide prevention strategies tailored for autistic individuals: the Safety Planning Intervention tailored for Autistic individuals (SPI-A) and SPI-A plus structured follow-up contacts (SPI-A+).

Description

This study includes three aims:

Aim 1: Among autistic youth (age 12-24) at risk for suicide, compare the effectiveness of SPI-A vs. SPI-A+. The primary outcomes of interest are suicidal ideation (SI) and suicidal behavior (SB). Secondary patient-centered outcomes are mental health treatment initiation and engagement, quality of life, well-being, skills to manage SI, access to lethal means, safety plan use, and acute care services for suicidality.

Aim 2: Compare implementation outcomes of acceptability and feasibility for the two interventions from the perspectives of patients, clinicians, and health system administrators.

Aim 3: Explore patient characteristics that may moderate the relationship between intervention and SI and SB.

Eligibility

Patient Participants

Inclusion Criteria:

  • 12-24 years old
  • Able and willing to provide informed consent (age ≥18) or assent and parental consent (age <18)
  • Able to speak English
  • Have received a safety plan tailored for autistic youth during a clinical visit

Exclusion Criteria:

  • Altered mental status that precludes ability to provide informed assent or consent (acute psychosis, intoxication, or mania)

Clinician Participants

Inclusion Criteria:

  • Employment as a provider serving autistic patients at one of the study sites
  • Employment in a role that involves suicide risk intervention with youth patients at a participating clinic
  • Able to read and speak English
  • Able and willing to provide informed consent
  • 18-99 years old

Exclusion Criteria:

  • There are no exclusion criteria for the clinician participants

Health System Leader Participants

Inclusion Criteria:

  • Health system or clinic leader at one of the study sites
  • Employed in a role that provides administrative oversight to clinicians conducting safety plans with patients
  • Able to read and speak English
  • Able and willing to provide informed consent
  • 18-99 years old

Exclusion Criteria:

  • There are no exclusion criteria for the health system leader participants

Study details
    Suicidal Ideation
    Suicidal and Self-injurious Behavior
    Suicide
    Autism Spectrum Disorder

NCT05398250

University of North Carolina, Chapel Hill

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.